RecruitingNCT04285125

High Resolution Imaging for Analysis of MVNT

High Resolution Imaging for Analysis of Multinodular and Vacuolating Neuronal Tumor of the Cerebrum


Sponsor

Fondation Ophtalmologique Adolphe de Rothschild

Enrollment

33 participants

Start Date

Mar 5, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

MVNT (multinodular and vacuolating neuronal tumor of the cerebrum) is a benign, recently discovered, neuronal lesion, the incidence of which is unknown. It seems to predominate in the temporal lobes and presents a characteristic MRI appearance: multiple subcortical nodules, developed at the white substance / gray substance junction, of variable size, well limited, in iso-hyposignal T1, hypersignal T2 and hypersignal FLAIR. The articles describing this entity report the lack of scalability in MRI during patient monitoring, going in the direction of the benignity of the lesion. The diagnosis sometimes remains uncertain with current MRI sequences, and the patient risks undergoing invasive surgery to remove a lesion that is actually benign. Hence the importance of developing the most precise diagnostic criteria possible. The contribution of advanced MRI techniques, such as ultra-high resolution sequences in the characterization of these lesions, has not yet been studied.


Eligibility

Min Age: 18 Years

Inclusion Criteria9

  • Patient over 18 years of age
  • Prospective inclusion of all patients with suspected MVNT on a first exploratory MRI: at least the 2 major criteria associated with at least 1 minor criterion will be required to fit into the definition of suspected MVNT:
  • Major criteria :
  • Multinomodular clustered appearance
  • Franc hypersignal FLAIR/T2
  • Minor criteria :
  • No mass effect
  • Hyposignal T1
  • Having received informed information about the study and having given express consent to participate in the study

Exclusion Criteria4

  • Contraindication to MRI
  • Patient benefiting from a legal protection measure
  • Pregnant or breastfeeding woman
  • \- No characterization MRI done

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERcerebral MRI

Patients who agree to participate in the study will perform an MRI with ultra high resolution sequences added by the research MRI of control will be done at one year and two years


Locations(7)

Groupe Hospitalier Pellegrin

Bordeaux, Bordeaux, France

CHU Rennes

Rennes, Rennes, France

CHU de Rouen

Rouen, Rouen, France

Hôpital Pierre Paul Riquet, CHU Purpan

Toulouse, Toulouse, France

Fondation A De Rothschild

Paris, France

Centre Hospitalier Lyon Sud

Pierre-Bénite, France

Hôpital Laennec

Saint-Herblain, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04285125